New abortifacient IUD Liletta approved by FDA
Liletta (levonorgestrel) Intrauterine Device – formerly Levosert
Company: Medicines360 and Actavis plc
Date of Approval: February 27, 2015
Treatment for: Contraception [abortifacient mechanism of action, chemically and mechanically]
Liletta (levonorgestrel) is a hormonal intrauterine device (IUD) for use by women to prevent pregnancy for up to three years. The basic mechanism of action is abortifacient by action of the progestin levonorgestrel–which is poor at supressing ovulation–and the mechanical irritation of the endometrium after junior has been conceived and implanted in the womb.
- FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Three Years– February 27, 2015
- Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert IUD– July 21, 2014
Advertisements
April 9, 2015 at 11:59
Reblogged this on EastSideHunky's Klobasa Klub and commented:
Update 4/6/15: Liletta was entered into the market this week and one unit is showing an AWP=$750….keep that in mind when you pay your taxes and insurance premiums, covering this at no copay charge so women can chemically abort their children the next 3 years and possibly come down with a serious illness from the IUD, even unto death… ESH